Timothy McPherson, Ph.D.
B.S., 1991, St. Louis College of Pharmacy
Ph.D., 1995, Purdue University
Research interests include drug and nutritional supplement delivery, pharmaceutical compounding and product quality, and implantable materials for tissue engineering. Recent projects include the formulation, in vitro testing, and in vivo evaluation of a soy extract for LDL cholesterol reduction; the processing and application of natural extracellular matrix biomaterials for wound healing; the role of compounded prescriptions in contemporary pharmacy practice.
2005 McPherson TB, Ostlund RE, Goldberg AC, Bateman JH, Schimmoeller L, and Spilburg CA. Phytostanol tablets reduce human LDL-cholesterol, Journal of Pharmacy and Pharmacology 57(7):889, 2005.
2003 Spilburg CA, Goldberg AC, McGill JB, Stenson WF, Racette SB, Bateman J, McPherson TB, and Ostlund RE. Fat-free foods supplemented with soy stanol-lecithin powder reduce cholesterol absorption and LDL cholesterol, Journal of the American Dietetic Association 103:577, 2003.
2001 Allman AJ, McPherson TB, Badylak SF, Liang HA, Swanson BR, HogenEsch H, Merrill L, Kallakury B, Sheehan C, Raeder RH, and Metzger DW. Xenogeneic extracellular matrix grafts elicit a Th2 restricted immune response. Transplantation 71:1631-1640, 2001.
2000 McPherson TB, Liang H, Record RD, and Badylak SF. Gal a (1,3)Gal epitope in porcine small intestinal submucosa. Tissue Engineering 6:233, 2000.
1998 McPherson TB and Badylak SF. Characterization of fibronectin derived from porcine small intestinal submucosa. Tissue Engineering 4:75,